OPKO Health, Inc. Share Repurchase Authorization
OPKO Health, Inc. (OPK) had Share Repurchase Authorization of $200.00 million as of 2025-04-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-28
- 2025-04-30: Stock Repurchase Program Authorized Amount1 $200.00M.
- 2025-04-04: Stock Repurchase Program Authorized Amount1 $200.00M.
- 2024-07-18: Stock Repurchase Program Authorized Amount1 $100.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2025-04-30 | $200.00M 10-Q/A · filed 2026-08-28 |
| 2025-04-04 | $200.00M 10-Q/A · filed 2026-08-28 |
| 2024-07-18 | $100.00M 10-Q/A · filed 2026-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |